CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jack W. Singer, M.D.
CTI BioPharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Scottsdale, Arizona, United States
- Scottsdale Medical Specialists
Scottsdale, Arizona, United States
- Hembree Regional Cancer Center
Fort Smith, Arkansas, United States
- Providence St. Joseph Medical Center
Burbank, California, United States
- Southwest Cancer Care
Escondido, California, United States
- Clinical Trials & Research Institute
Montebello, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Broward Oncology Associates
Fort Lauderdale, Florida, United States
- Horizon Institute for Clinical Research
Hollywood, Florida, United States
- Memorial Cancer Institute
Hollywood, Florida, United States
- Pasco Pinellas Cancer Center
Tarpon Springs, Florida, United States
- Joliet Oncology Hematology Associates, Ltd
Joliet, Illinois, United States
- Loyola University
Maywood, Illinois, United States
- Hematology Oncology Consultants
Naperville, Illinois, United States
- Cancer Care Center
New Albany, Indiana, United States
- Providence Medical Group
Terre Haute, Indiana, United States
- Family Medicine of Vincennes Clinical Trials Center
Vincennes, Indiana, United States
- Kansas City Cancer Center
Overland Park, Kansas, United States
- Henry Ford Health System, Josephine Ford Cancer Center
Detroit, Michigan, United States
- W. Michigan Regional Cancer & Blood Center
Free Soil, Michigan, United States
- Hattiesburg Clinic
Hattiesburg, Mississippi, United States
- Columbia Comprehensive Cancer Care Clinics
Jefferson City, Missouri, United States
- St. Louis University
St Louis, Missouri, United States
- Las Vegas Cancer Center
Henderson, Nevada, United States
- Va Sierra Nevada Health Care System
Reno, Nevada, United States
- Arena Oncology Associates
New York, New York, United States
- Lincoln Medical and Mental Health Center
New York, New York, United States
- Richmond University Medical Center
Staten Island, New York, United States
- New York Medical College
Valhalla, New York, United States
- St Alexius Medical Center
Bismarck, North Dakota, United States
- Blood and Cancer Center
Canfield, Ohio, United States
- Aultman Hospital Clinical Trials
Canton, Ohio, United States
- Uima, Inc / University of Cincinnati-Barrett Cancer Center
Cincinnati, Ohio, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- Vita Hematology Oncology, P.C.
Fountain Hill, Pennsylvania, United States
- the Family Cancer Center
Collierville, Tennessee, United States
- Mid-South Cancer Center
Germantown, Tennessee, United States
- Lone Star Oncology Consultants
Austin, Texas, United States
- Southwest Regional Cancer Center
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2007
- Primary completion
- 5 Apr 2010
- Completion
- 5 Apr 2010
- Last update posted
- 19 Oct 2020
- Registered enrollment
- 0
- Registry id
- NCT00576225
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.